PolicyView™ is a PC and iPad compatible application that houses a comprehensive library of reimbursement policies for Specialty Drugs across 44 leading payers in the U.S.
PolicyView™ characterizes the key criteria for authorization and utilization of therapies in Rheumatoid Arthritis, Psoriasis, Multiple Sclerosis, Crohns/Ulcerative Colitis, Lupus, and the leading Oncology malignancies (Breast Cancer, Colorectal Cancer, Prostate Cancer, Lung Cancer and Melanoma).
This user-friendly interface allows for individual and comparative assessment of payer utilization management criteria for medical policies and the added capability to search and extract portions of policies, based on keywords.
PolicyView’s analysis and query functions lets users access the most up-to-date coverage policies for specialty brands.
Pharmspective’s ongoing surveillance of payer policies gives subscribers confidence that they have the most recent reimbursement criteria representing the majority of total insured lives in the U.S.
Pharmspective, LLC creates Data Visualization tools that simplify the understanding of key insights derived from its proprietary primary and secondary market research on Market Access for Specialty Therapeutics. Our research studies examine clinical decision-making, drug acquisition, access and reimbursement, and patient administration for specialty drugs. Our data visualization tools provide state-of-the-art user interfaces that allow our customers to look at market intelligence from a wide range of perspectives with PC-based and Tablet applications. Pharmspective’s Healthcare Reform team provides insights into the Affordable Care Act through its proprietary ClearView™ state-of-the-art-app on iPad® or PC. Our ACA Market Access Reports detail the impact of the ACA on key states and HealthCareReformInsider.com provides the latest news on the ACA.